TELUS International Q1 Adj. Profit Rises

TELUS International (TIXT) reported first quarter adjusted EPS of $0.23, up 229% from last year. Adjusted net income was 293% higher at $59 million. Adjusted EBITDA was $129 million, up 90% from a year ago.

First quarter net income was $3 million and EPS was $0.01, compared to $11 million and $0.05, prior year.

First quarter revenue was $505 million, up 57%, due to contributions from acquisitions,
with organic growth of 20%. Team member count was 51,387 as of March 31, 2021, an increase of 11%.

For 2021, the company expects: adjusted EPS in a range of $0.90 to 0.95; and revenue of $2.15 billion to $2.19 billion.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The 737 MAX 10, Boeing Co.'s largest 737 Max model, is taking its maiden flight today, reports said citing people familiar with the matter. The flight after months of testing and certification will be around 10 a.m. local time from the Seattle area. The schedule could change depending on weather or other factors. Meanwhile, the jetliner is expected to enter commercial service in 2023. Medical devices supplier Smiths Medical, affiliated to Smiths Group plc, is recalling certain Jelco Hypodermic Needle-Pro Fixed Needle insulin syringes with skewed graduation markings, the U.S. Food and Drug Administration said. The recall was initiated after the company became aware of specific models and lots of Jelco insulin syringes that may exhibit skewed odd number line graduation markings. Saliva-based COVID-19 testing is rolled out as a pilot for public schools in New York City. The new two-month pilot program is being implemented in about 50 New York City public schools and utilizes Fluidigm Technology to offer RT-PCR COVID-19 testing. New York City public schools have instituted mandatory random weekly testing in all reopened school buildings to ensure safer in-person learning.
Follow RTT